Navigation Links
Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance
Date:10/27/2010

10-Benefit related to client contract amendment (2)

--(0.03)-Transaction-related costs (3)

-0.02-0.03Benefit related to insurance recovery  (4)

---(0.02)Termination of bridge financing (5)

---0.07Legal settlement (6)

-0.04-0.04Amortization of: Legacy intangible assets (7)

0.010.010.030.03NextRx-related intangible assets (8)

0.04-0.10-EPS from continuing operations, adjusted$  0.65$ 0.42$  1.80$ 1.30EPS from discontinued operations, as reported$ (0.01)$
-$ (0.04)$
-Non-recurring items: Impairment and other charges (9)

0.01-0.04-EPS from discontinued operations, adjusted$
-$
-$
-$
-Total EPS, adjusted$  0.65$  -$ 0.42$  1.79$ 1.30 The Company is providing diluted earnings per share excluding the impact of non-recurring charges and intangibles amortization in order to compare the underlying financial performance to prior periods. (1)Integration-related costs include those costs directly related to the acquisition of NextRx, primarily comprised of transition services, integration, site closures and severance costs of $15.1 million ($9.5 million net of tax) and $62.7 million ($39.5 million net of tax) included in cost of revenues for the three and nine months ended September 30, 2010, respectively.
Additionally, the Company incurred integration-related costs of $12.3 million ($7.7 million net of tax) and $22.7 million ($14.3 million net of tax) included in selling, general and administrative expense in the three and nine months ended September 30, 2010, respectively. (2) Non-recurring benefit relating to an amendment of a client contract of $30.0 million ($18.9 million net of tax) is included as an increase to revenue for the nine months ended September 30, 2010.   This amount was originally accrued in the NextRx opening balance sheet and, in accordance with business combination accounting guidance, the reversal of the accrual was recorded in revenue, since it
'/>"/>

SOURCE Express Scripts, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. ALS TDI Completes Gene Expression Profile of Lou Gehrigs Disease in Mice
2. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
3. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
4. TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries
5. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
6. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
7. Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients
8. International Medical Corps Matched with Top 25 American Express Members Project, Saving the Lives of Malnourished Children
9. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
10. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Rolta gab ... Sadara Chemical Company (Sadara) erhalten zu haben, ... des integrierten Chemiekomplexes von Sadara in Jubail ... im Wert von mehreren Millionen Dollar stellt ... dessen Wert sich ebenfalls auf mehrere Millionen ...
(Date:7/22/2014)...  Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 2014 on Thursday, July 31, 2014, after the close of ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ... through a link that is posted on the home page ...
(Date:7/22/2014)... 22, 2014  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, announced that Edwards, Chairman ... as an expert panelist at the invitation of the ... to discuss medical device innovation at its hearing, "21 ... Development and Communication." "Edwards has five decades ...
Breaking Medicine Technology:Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2
... N.C. , July 21 /PRNewswire-FirstCall / -- SPX ... completed the acquisition of the Anhydro business, a Soeborg, Denmark ... dewatering plants and equipment.  The terms of the transaction were not ... Anhydro ...
... DETROIT , July 21 Caraco Pharmaceutical ... shipping bupropion hydrochloride extended release tablets. This product was ... (FDA) for Sun Pharma,s Abbreviated New Drug Application (ANDA). ... mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline,s ...
Cached Medicine Technology:SPX Completes Acquisition of Anhydro 2SPX Completes Acquisition of Anhydro 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets 2
(Date:7/23/2014)... July 23, 2014 QueenBeeTickets.com is reducing the ... a coup for rock music fans who are still in ... buyers visit the site, they can use promo code “DISCOUNT” ... Here to view the inventory of discounted tickets at ... in August, September and October, with The Eagles concert tickets ...
(Date:7/23/2014)... Temecula Valley Southern California Wine Country, ... Wine Country artisan food and wine experiences combine ... nourishing. Savor like locals at Briar Rose, Cougar, ... EAT Marketplace, Palumbo’s Ristorante, Robin’s Nest, Old Town ... Kimberly Adams, president and CEO, Visit Temecula Valley ...
(Date:7/23/2014)... In an effort to help advance ... Disease” at the state level, the National Alliance ... of America (AFA) this week released a white ... and the need for wide-scale implementation of state plans ... The white paper outlines recommendations for both ...
(Date:7/23/2014)... living with multiple chronic medical conditions, a new study ... Health finds that the more ailments you have after ... one of the first to examine the burden of ... may help explain why increases in life expectancy among ... findings, based on an analysis of 1.4 million Medicare ...
(Date:7/22/2014)... July 23, 2014 Recently, iFitDress.com, a popular ... has announced its new selection of white party dresses ... that custom made outfits are now available on its website. ... before the end of July can get a discounted rate, ... products are popular among international customers, so its marketing specialist ...
Breaking Medicine News(10 mins):Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 3Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 4Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 2Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 3Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 2Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 3Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... of the AMA,board, HONOLULU, Hawaii, Nov. 13 ... Inc., has been newly elected,to the American Medical Association ... today. Mr. Kay will be the,only non-physician member on ... the position., Mr. Kay has spent his career ...
... Nov. 13 Nastech,Pharmaceutical Company Inc. ("Nastech") (Nasdaq: ... Directors has approved the recommendation of its Special,Committee ... Nastech,s,wholly-owned subsidiary, MDRNA, Inc. ("MDRNA"), as an independent ... related to,RNA interference ("RNAi") into MDRNA. The new ...
... BOTHELL, Wash., Nov. 13 Nastech,Pharmaceutical Company ... its,corporate restructuring initiatives aimed at reducing operating expenses,and ... its,subsidiary, MDRNA, Inc., as an independent, separately financed ... Phase 2 clinical and partnered,programs as well as ...
... (SWX:,ROG.VX; RO.S) confirmed today that it has entered into ... VMSI ) and that it,will commence due diligence. Roche ... with respect to the acquisition of Ventana will be,reached. ... offer to acquire all of the,outstanding common shares of ...
... of sound in medicine has a long history. Doctors have ... human body since the early 19th century, and ultrasound imaging ... the United States typically know the gender of their offspring ... pregnancy. , Now scientists are finding many more advanced applications ...
... A gene linked to pediatric brain tumors is an essential ... of Medicine in St. Louis have found. , The study, ... neurofibromatosis 1 (NF1) gene helps push stem cells down separate ... brain cells: support cells known as astrocytes and brain neurons. ...
Cached Medicine News:Health News:Fortune 500 Executive Elected to AMA Board of Trustees 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 3Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 4Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 2Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 3Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 4Health News:Roche Confirms Commencement of Due Diligence with Ventana 2Health News:Roche Confirms Commencement of Due Diligence with Ventana 3Health News:Roche Confirms Commencement of Due Diligence with Ventana 4Health News:Sound medicine at Acoustics Meeting 2Health News:Sound medicine at Acoustics Meeting 3Health News:Sound medicine at Acoustics Meeting 4Health News:Sound medicine at Acoustics Meeting 5Health News:Sound medicine at Acoustics Meeting 6Health News:Sound medicine at Acoustics Meeting 7Health News:Sound medicine at Acoustics Meeting 8Health News:Cancer gene drives pivotal decision in early brain development 2Health News:Cancer gene drives pivotal decision in early brain development 3
Fulgurating Electrode, 3 F...
... Flexible CystoNephroscope is used for percutaneous and ... practice. The large 6.4 Fr (2.1 mm) ... operating instruments for therapeutic applications. The flexible ... covered tip provide fast, less traumatic access ...
Inquire...
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: